Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I8FO
|
|||
| Former ID |
DIB002013
|
|||
| Drug Name |
ABI-0043
|
|||
| Synonyms |
ABI-0036N; ABI-0042N; ABI-0047N; ABI-0073N; ABI-0094; ABI-0185N; ABI-0197N; ABI-0299; ABI-0369; ABI-0597; ABI-0699; ABI-0710; ABI-0710N; ABI-0713; ABI-0761; ABI-0761N; ABI-0933; ABI-0966N; ABI-0971; ABI-1131; ABI-1162; ABI-1339; ABI-1657; ABI-1662; ABI-1808; Rifalazil analogs, ActivBiotics; Rifalazil derivatives (antibacterial); Rifalazil derivatives (antibacterial), ActivBiotics
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Respiratory tract infection [ICD-11: CA45; ICD-10: J00-J99; ICD-9: 460-519] | Preclinical | [1] | |
| Company |
ActivBiotics Inc
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C46H56N4O12
|
|||
| Canonical SMILES |
CC1C=CC=C(C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)O)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)C)O3)C
|
|||
| InChI |
1S/C46H56N4O12/c1-21-11-10-12-22(2)45(58)48-36-41(56)32-31(35-43(36)61-30-20-27(19-28(51)34(30)47-35)50-16-14-49(8)15-17-50)33-42(26(6)40(32)55)62-46(7,44(33)57)60-18-13-29(59-9)23(3)38(53)25(5)39(54)24(4)37(21)52/h10-13,18-21,23-25,29,37-39,52-55,57H,14-17H2,1-9H3,(H,48,58)/b11-10+,18-13+,22-12-/t21-,23+,24+,25-,29-,37-,38+,39+,46-/m0/s1
|
|||
| InChIKey |
XTWSBXHGYIWJJV-PMXQCPMZSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021301) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.